JPMorgan Chase (JPM) has released its fourth-quarter 2025 earnings, surpassing analysts' estimates. This signals the start of the Q4 earnings season, with other major financial institutions set to report later in the week. The results refle...
JPMorgan Chase & Co. (JPM) is under scrutiny in early 2026 as institutional investors adjust their positions and the company prepares to take over the Apple Card. This analysis recaps recent market activity and sentiment surrounding JPM sto...
Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play
JPMorgan Chase (JPM) is scheduled to release its third-quarter earnings report before the market opens on Tuesday, October 14, 2025. Investors and analysts will be closely watching the results for insights into consumer and corporate financ...
Fresenius climbs as JPM puts stock on Positive Catalyst Watch on Helios tailwinds
This article provides an overview of recent AI-driven analysis of JPMorgan Chase & Co. (JPM), focusing on potential trading strategies, risk-reward setups, and key signals across different time horizons. Stay informed about market dynamics...
JPMorgan Chase (JPM) is set to release its second-quarter earnings, offering insights into U.S. consumer and corporate financial health. Investors are eager to gauge consumer sentiment and the potential impact of economic factors, including...
JPMorgan Chase is set to report second-quarter earnings – here’s what the Street expects
JPMorgan Chase & Co. (JPM) has secured a significant regulatory win after CEO Jamie Dimon challenged what he viewed as excessive regulatory oversight. This development has paved the way for substantial shareholder benefits.
JPMorgan Chase Ups Dividend, Approves $50 Billion Buyback After Stress Test - WSJ